Biostar Pharmaceuticals, Inc. Announces Second Quarter 2014 Financial Results
— Revenue increased by 31% to $19.2 million
— Net income increased to $1.65 million as compared to a net loss of $.73 million last year
— Diluted EPS of $0.11
XIANYANG, China, August 14, 2014 /PRNewswire/ — Biostar Pharmaceuticals, Inc. (NASDAQ: BSPM) (“Biostar” …
Read More